Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bentracimab for Ticagrelor Reversal (REVERSE-IT)
NCT04286438Phase 3Completed
- Sponsor
- SFJ Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Sep 2024
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 3 trial of bentracimab in hemorrhage, sponsored by SFJ Pharmaceuticals. Started Jul 2020; status: completed.
02
Drugs
bentracimab
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04286438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04286438.